Crescent Capital Valuation
| CCAP Stock | USD 19.18 0.04 0.21% |
At this time, the firm appears to be overvalued. Crescent Capital BDC shows a prevailing Real Value of $18.27 per share. The current price of the firm is $19.18. Our model approximates the value of Crescent Capital BDC from analyzing the firm fundamentals such as profit margin of 0.47 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Crescent Capital's valuation include:
Price Book 0.9513 | Enterprise Value 1.6 B | Price Sales 3.5456 | Forward PE 9.4251 | Trailing PE 7.5216 |
Overvalued
Today
Please note that Crescent Capital's price fluctuation is very steady at this time. Calculation of the real value of Crescent Capital BDC is based on 3 months time horizon. Increasing Crescent Capital's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Crescent Capital's intrinsic value may or may not be the same as its current market price of 19.18, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.18 | Real 18.27 | Target 17.75 | Hype 19.25 | Naive 19.38 |
The intrinsic value of Crescent Capital's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Crescent Capital's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Crescent Capital BDC helps investors to forecast how Crescent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Crescent Capital more accurately as focusing exclusively on Crescent Capital's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Crescent Capital's intrinsic value based on its ongoing forecasts of Crescent Capital's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Crescent Capital's closest peers.
Crescent Capital Cash |
|
Crescent Valuation Trend
Crescent Capital's real value is important for investors to make better decisions and a more accurate overall view of Crescent Capital's financial worth over time. Using both Crescent Capital's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Crescent Capital Total Value Analysis
Crescent Capital BDC is currently forecasted to have valuation of 1.55 B with market capitalization of 712.32 M, debt of 844.78 M, and cash on hands of 9.41 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Crescent Capital fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.55 B | 712.32 M | 844.78 M | 9.41 M |
Crescent Capital Investor Information
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Crescent Capital BDC has Price/Earnings To Growth (PEG) ratio of 0.89. The entity last dividend was issued on the 29th of November 2024. Based on the analysis of Crescent Capital's profitability, liquidity, and operating efficiency, Crescent Capital BDC is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.Crescent Capital Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Crescent Capital has an asset utilization ratio of 10.61 percent. This connotes that the Company is making $0.11 for each dollar of assets. An increasing asset utilization means that Crescent Capital BDC is more efficient with each dollar of assets it utilizes for everyday operations.Crescent Capital Ownership Allocation
Crescent Capital holds a total of 37.06 Million outstanding shares. 30% of Crescent Capital BDC outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Crescent Capital Profitability Analysis
The company reported the previous year's revenue of 172.69 M. Net Income was 83.84 M with profit before overhead, payroll, taxes, and interest of 116.72 M.Crescent Capital Past Distributions to stockholders
About Crescent Capital Valuation
The stock valuation mechanism determines Crescent Capital's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Crescent Capital BDC based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Crescent Capital. We calculate exposure to Crescent Capital's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Crescent Capital's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 136.1 M | 142.9 M | |
| Pretax Profit Margin | 0.46 | 0.48 | |
| Operating Profit Margin | 0.77 | 0.81 | |
| Net Profit Margin | 0.46 | 0.48 | |
| Gross Profit Margin | 0.74 | 0.78 |
A single share of Crescent Capital represents a small ownership stake in the entity. As a stockholder of Crescent, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Crescent Capital Dividends Analysis For Valuation
At this time, Crescent Capital's Dividends Paid is relatively stable compared to the past year. As of 11/26/2024, Dividend Payout Ratio is likely to grow to 0.84, while Dividend Yield is likely to drop 0.05. . At this time, Crescent Capital's Earnings Yield is relatively stable compared to the past year. As of 11/26/2024, Price Earnings Ratio is likely to grow to 7.82, though Retained Earnings are likely to grow to (212.2 M).
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 64.5 M | 67.8 M | |
| Dividend Yield | 0.10 | 0.05 | |
| Dividend Payout Ratio | 0.77 | 0.84 | |
| Dividend Paid And Capex Coverage Ratio | 1.43 | 1.50 |
There are various types of dividends Crescent Capital can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Crescent shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Crescent Capital BDC directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Crescent pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Crescent Capital by the value of the dividends paid out.
Crescent Capital Growth Indicators
Investing in growth stocks can be very risky. If the company such as Crescent Capital does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 35.9 M | |
| Quarterly Earnings Growth Y O Y | -0.325 | |
| Forward Price Earnings | 9.4251 |
Crescent Capital Current Valuation Indicators
Crescent Capital's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Crescent Capital's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Crescent Capital, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Crescent Capital's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Crescent Capital's worth.Additional Tools for Crescent Stock Analysis
When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.